Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
1.5K
Total Open
Publications
654
Total
Citations
52K
Open Access
Percentage
42%
Total
Publications
1.5K
Total Open
Publications
654
Total
Citations
52K
Breakdown
Publisher Open
18%
Both
20%
Other Platform Open
4%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
197
Hybrid 29%
167
No Guarantees 37%
215
Other Platform Open
Domain 79%
299
Institution 22%
82
Other Internet 14%
53
Preprint 3%
11
Public 2%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 299 |
DOI | Other Internet | 50 |
Royal Netherlands Academy of Arts and Sciences | Institution | 36 |
universiteitleiden.nl OAI-PMH Repository | Institution | 10 |
Europe PMC | Domain | 10 |
Harvard University | Institution | 8 |
Yonsei University | Institution | 7 |
Harris County Public Library | Institution | 6 |
Figshare | Public | 6 |
University of Milan | Institution | 5 |